Validation of proteomic biomarkers previously found to be differentially expressed in women with Polycystic Ovary Syndrome: a cross-sectional study

References

• Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19–25
   Web of Science ®Google Scholar
• Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774–800
   PubMed Web of Science ®Google Scholar
• Legro RS, Driscoll D, Strauss JF 3rd, et al. Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome. Proc Natl Acad Sci USA 1998;95:14956–60
   PubMed Web of Science ®Google Scholar
• March WA, Moore VM, Willson KJ, et al. The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Hum Reprod 2010;25:544–51
   PubMed Web of Science ®Google Scholar
• Pasquali R, Stener-Victorin E, Yildiz BO, et al. PCOS Forum: research in polycystic ovary syndrome today and tomorrow. Clinical Endocrinol 2011;74:424–33
   PubMed Web of Science ®Google Scholar
• Atiomo W, Khalid S, Parameshweran S, et al. Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review. BJOG 2009;116:137–43
   PubMed Web of Science ®Google Scholar
• Atiomo WU, Khalid S, Ziauddin A, et al. Framework for a systems approach to proteomic biomarker profiling in polycystic ovary syndrome. Expert Rev Proteomics 2009;6:469–99
   PubMed Web of Science ®Google Scholar
• Urbanek M, Legro RS, Driscoll DA. Thirty-seven candidate genes for polycystic ovary syndrome: strongest evidence for linkage is with follistatin. Proc Nat Acad USA 1999;96:8573–8
   PubMed Web of Science ®Google Scholar
• Hughes C, Elgasim M, Layfield R, Atiomo W. Genomic and post-genomic approaches to polycystic ovary syndrome-progress so far: mini review. Hum Reprod 2006;21:2766–75
   PubMed Web of Science ®Google Scholar
• Luque-Ramirez M, San Millan JL, Escobar-Morreale HF. Genomic variants in polycystic ovary syndrome. Clin Chim Acta 2006;366:14–26
   PubMed Web of Science ®Google Scholar
• Goodarzi MO. Looking for polycystic ovary syndrome genes: rational and best strategy. Sem Rep Med 2008;26;1:5–13
   Google Scholar
• Chen ZJ, Zhao H, He L, et al. Genome-wide association study identifies susceptibility loci for polycystic ovary syndrome on chromosome 2011;2p16.3, 2p21 and 9q33.3. Nat Genet 43:55–9
   Google Scholar
• Matharoo-Ball B, Hughes C, Lancashire L, et al. Characterization of biomarkers in polycystic ovary syndrome (PCOS) using multiple distinct proteomic platforms. J Proteome Res 2007;6:3321–8
   PubMed Web of Science ®Google Scholar
• Ma X, Fan L, Meng Y, et al. Proteomic analysis of human ovaries from normal and polycystic ovarian syndrome. Mol Hum Reprod 2007;13:527–35
   PubMed Web of Science ®Google Scholar
• Choi BC, Kim YS, Kim MS, et al. Identification of over expressed proteins by proteomic analysis using human follicular fluids derived from polycystic ovary syndrome (PCOS) patients. Fertil Steril 2007;88:S180
   Google Scholar
• Corton M, Botella-Carretero JI, Lopez JA, et al. Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod 2008;23:651–61
   PubMed Web of Science ®Google Scholar
• Insenser M, Martínez-García MA, Montes R, et al. Proteomic analysis of plasma in the polycystic ovary syndrome identifies novel markers involved in iron metabolism, acute-phase response, and inflammation. J Clin Endocrinol Metab 2010;95:3863–70
   PubMed Web of Science ®Google Scholar
• Zhao Y, Fu L, Li R, et al. Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med 2012;10:153
   PubMed Web of Science ®Google Scholar
• Sun L, Hu W, Liu Q, et al. Metabonomics reveals plasma metabolic changes and inflammatory marker in polycystic ovary syndrome patients. J Proteome Res 2012;11:2937–46
   PubMed Web of Science ®Google Scholar
• Escobar-Morreale HF, Samino S, Insenser M, et al. Metabolic heterogeneity in polycystic ovary syndrome is determined by obesity: plasma metabolomic approach using GC-MS. Clin Chem 2012;58:999–1009
   PubMed Web of Science ®Google Scholar
• Atiomo W, Daykin CA. Metabolomic biomarkers in women with polycystic ovary syndrome. A pilot study. Mol Hum Reprod 2012;18:546–53
   PubMed Web of Science ®Google Scholar
• Dai G, Lu G. Different protein expression patterns associated with polycystic ovary syndrome in human follicular fluid during controlled ovarian hyperstimulation. Reprod Fertil Dev 2012;24:893–904
   PubMed Web of Science ®Google Scholar
• Choi DH, Lee WS, Won M, et al. The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis. J Proteome Res 2010;9:4329–36
   PubMed Web of Science ®Google Scholar
• Misiti S, Stigliano A, Borro M, et al. Proteomic profiles in hyperandrogenic syndromes. J Endocrinol Invest 2010;33:156–64
   PubMed Web of Science ®Google Scholar
• Zhao SY, Qiao J, Li MZ, et al. Preliminary study of protein expression profiling of PCOS on different state. Zhonghua Yi Xue Za Zhi 2008;88:7–11
   PubMedGoogle Scholar
• Borro M, Gentile G, Stigliano A, et al. Proteomic analysis of peripheral T lymphocytes, suitable circulating biosensors of strictly related diseases. Clin Exp Immunol 2007;150:494–501
   PubMed Web of Science ®Google Scholar
• Zhao S, Qiao J, Li M, et al. Discovery of distinct protein profiles for polycystic ovary syndrome with and without insulin resistance by surface-enhanced laser adsorption/ionization time of flight mass spectrometry. Fertil Steril 2007;88:145–51
   PubMed Web of Science ®Google Scholar
• Chiellini C, Santini F, Marsili A, et al. Serum haptoglobin: a novel marker of adiposity in humans. J Clin Endocrinol Metab 2004;89:2678–83
   PubMed Web of Science ®Google Scholar
• De Pergola G, Di Roma P, Paoli G, et al. Haptoglobin serum levels are independently associated with insulinemia in overweight and obese women. J Endocrinol Invest 2007;30:399–403
   PubMedGoogle Scholar